Body
View this post on the web at https://derekpruski.substack.com/p/pcos-has-a-new-name-meet-pmos-polyendocrine
Everything below is for research and educational purposes only. Nothing here is medical advice. If this affects you personally, talk to a qualified clinician.
The Update
If you saw my earlier PCOS post — there’s a major update.
As of May 12, 2026, PCOS has officially been renamed.
The new name is PMOS: Polyendocrine Metabolic Ovarian Syndrome.
The change was published in The Lancet by an international consensus group led by Professor Helena Teede of Monash University. It took 14 years of work and involved more than 14,000 patients and clinicians from every region of the world to get this across the finish line.
The condition itself didn’t change. The biology is the same. What changed is the official recognition that this is not a disease of the ovaries. It’s a whole-body metabolic and hormonal condition that happens to show up in the ovaries.
That distinction is the entire point.
Why The Old Name Was A Problem
The old name pointed at the wrong thing.
“Polycystic ovary syndrome” made it sound like the problem was cysts on the ovaries. Two issues with that.
First — those aren’t actually cysts. When an ultrasound shows the “polycystic” appearance, what you’re seeing are eggs that started developing and got stuck partway through. They never matured. They never released. They just stalled. They look like little fluid-filled sacs, which is why they got called cysts, but they’re not the same thing as the cysts you’d think of in other conditions.
Second — even those stalled eggs aren’t the actual disease. They’re a symptom. The real problem is happening somewhere else entirely, and the ovaries are just where you can see it on a screen.
Think of it like this: if your car keeps overheating, the temperature gauge isn’t the problem. It’s telling you something is wrong with the engine. Calling it “polycystic ovary syndrome” is like calling your car trouble “high temperature gauge disease.” It points at the symptom, not the cause.
This matters because the wrong name has led to the wrong care for decades. About 1 in 8 women globally have this condition. That’s around 170 million people. And up to 70 percent of them are walking around undiagnosed — partly because the name made everyone think it was a niche ovary issue instead of a major whole-body metabolic problem.
What’s Actually Happening
This is the part most people never get explained clearly. Here’s the simple version.
There are four things going wrong, and they all push on each other in a loop.
Problem 1: Insulin stops working properly
Insulin is the hormone that tells your cells to absorb sugar from your blood. In PMOS, the cells stop listening. So your body’s response is to make more insulin to force the message through. Now you’ve got way too much insulin floating around in your blood all the time.
This is called insulin resistance, and it’s the root of the whole condition.
Problem 2: Too much insulin tells the ovaries to make too much testosterone
Here’s something most people don’t know — insulin doesn’t just regulate blood sugar. It also talks directly to the ovaries. When insulin levels are high, it signals the ovaries to crank out extra testosterone and other male-pattern hormones (called androgens).
That’s why PMOS shows up as acne, unwanted hair growth, and hair thinning. It’s not a skin problem or a hair problem. It’s an insulin problem showing up on the surface.
Problem 3: The brain’s cycle signals get scrambled
Your brain controls your menstrual cycle by sending out timed hormone pulses. In PMOS, those pulses get out of rhythm. The brain sends out too much of one signal (LH) and not enough of another (FSH).
FSH is the signal that tells eggs to mature. Without enough of it, eggs start developing but never finish.
Problem 4: Eggs stall instead of ovulating
Because the FSH signal is weak, eggs get stuck in development. They don’t mature, they don’t release, and ovulation doesn’t happen the way it should. That’s what creates the “polycystic” look on ultrasound — a bunch of half-developed eggs sitting there waiting.
No ovulation also means no progesterone, which means cycles become irregular or skip entirely.
The trap: all four problems make each other worse
Insulin resistance drives high testosterone. High testosterone makes insulin resistance worse. The scrambled brain signals push both of them further. The ovaries get caught in the middle.
The ovaries aren’t broken. They’re responding exactly the way you’d expect them to in this hormonal environment. Fix the environment and the ovaries usually start working again.
This is why “polyendocrine metabolic” is the right name:
Poly means many
Endocrine means hormone systems
Metabolic means how your body processes energy
There are many hormone systems involved, and the engine running underneath all of it is metabolic.
Why The Name Change Matters
A name change sounds cosmetic. It’s not. Here’s what actually shifts when the framing shifts.
Doctors think differently
When a doctor hears “polycystic ovary syndrome,” they think: do an ultrasound, look at the ovaries, refer to a gynecologist. The workup focuses on reproductive structure.
When a doctor hears “polyendocrine metabolic ovarian syndrome,” they think: check insulin, check cholesterol, check cardiovascular risk, check the full hormonal picture. The ovary findings become one piece of a much bigger investigation.
That’s a completely different standard of care. And it’s the one that actually matches the biology.
Research gets better funded
Research grants and journals categorize conditions by name. “Reproductive disorders” is a smaller, historically underfunded research pool. “Endocrine and metabolic disorders” is a much bigger one — the same pool that funds diabetes, obesity, and heart disease research.
Just by changing the name, this condition gets access to far more research money, attention, and crossover with other metabolic science.
Stigma drops
The old name forced reproductive language into every conversation about it. In many cultures, that created shame and made people less likely to seek care or talk about it openly.
The new name is medical and metabolic. It describes a body system, not a reproductive label.
Patients ask better questions
When you know your condition is metabolic, you start tracking the right things. You ask about insulin, A1C, fasting glucose, lipid panels — not just whether your cycle is regular. You see it as a long-term health condition with cardiovascular and metabolic implications, not just a fertility issue.
What Didn’t Change
The diagnosis itself stayed exactly the same. You still need two out of three of these:
Irregular or absent ovulation
High androgens (testosterone-type hormones)
Polycystic ovaries on ultrasound, or elevated AMH (a hormone that reflects egg supply)
For teenagers, the third criterion isn’t used by itself because polycystic-looking ovaries can be normal in adolescence.
What also didn’t change immediately is treatment. But the framing now points clinicians toward addressing the metabolic root — insulin sensitivity, body composition, long-term cardiovascular risk — rather than just managing symptoms.
The Rollout
This is a managed 3-year transition. Both names will be in use during that time. That’s normal and expected.
Medical records, textbooks, and training programs are migrating now. The official International Guideline (used in 195 countries) updates in 2028. The WHO is adding PMOS to the official disease classification system.
You’ll see “PCOS/PMOS” or both names together for a while. Eventually it’ll just be PMOS.
Why This Matters For Us
For anyone paying attention to metabolic research, this rename is huge.
For years, the research community has been saying this is a metabolic condition. Now the official name says it too.
That means the broader conversation around insulin sensitivity, GLP-1 mechanisms, mitochondrial function, and metabolic optimization is now formally relevant to PMOS. Expect a lot more crossover between the metabolic research space and the PMOS literature over the next few years.
If you missed the earlier post on the metabolic side of all this, the biology I covered still applies. Same condition. Same hormonal cascade. Just a better name for it.
References
The Lancet — official consensus publication: Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. 2026. Read the full publication [ https://substack.com/redirect/91312562-6e86-4368-bb8b-d90912809dcc?j=eyJ1IjoiNGl3b2U2In0.sVDxRtmZ85v8kfdamY0krRXGMy3p768BWtuZifRB-Zs ]
Monash University press release: Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide [ https://substack.com/redirect/aeb6633f-a634-494f-b2b0-dca755e040d2?j=eyJ1IjoiNGl3b2U2In0.sVDxRtmZ85v8kfdamY0krRXGMy3p768BWtuZifRB-Zs ]
International PCOS Guideline (Monash): Monash Centre for Health Research & Implementation — PCOS Guideline [ https://substack.com/redirect/9193435f-47f9-4a3a-b6d4-09e336327e38?j=eyJ1IjoiNGl3b2U2In0.sVDxRtmZ85v8kfdamY0krRXGMy3p768BWtuZifRB-Zs ]
WHO PCOS Fact Sheet: World Health Organization — Polycystic Ovary Syndrome [ https://substack.com/redirect/0e65eafc-5cc8-46c9-821e-1ab6cb2b983e?j=eyJ1IjoiNGl3b2U2In0.sVDxRtmZ85v8kfdamY0krRXGMy3p768BWtuZifRB-Zs ]
Unsubscribe https://substack.com/redirect/2/eyJlIjoiaHR0cHM6Ly9kZXJla3BydXNraS5zdWJzdGFjay5jb20vYWN0aW9uL2Rpc2FibGVfZW1haWw_dG9rZW49ZXlKMWMyVnlYMmxrSWpveU56TTJNakl6T1Rnc0luQnZjM1JmYVdRaU9qRTVOelF6TVRRNE1pd2lhV0YwSWpveE56YzROak0wTnprd0xDSmxlSEFpT2pFNE1UQXhOekEzT1RBc0ltbHpjeUk2SW5CMVlpMHpNelkxTXpZM0lpd2ljM1ZpSWpvaVpHbHpZV0pzWlY5bGJXRnBiQ0o5LkNuY3dFNTVQSnpRdjZ0MTZOT1hrbWlpS0tfR0dVM3EyS1c3elB3dWM3bkUiLCJwIjoxOTc0MzE0ODIsInMiOjMzNjUzNjcsImYiOnRydWUsInUiOjI3MzYyMjM5OCwiaWF0IjoxNzc4NjM0NzkwLCJleHAiOjIwOTQyMTA3OTAsImlzcyI6InB1Yi0wIiwic3ViIjoibGluay1yZWRpcmVjdCJ9.8N8-pt4NyHyxP2UmxpWd1ERs4WXCjOgZr2SjS02Re18?